NEWS October, 2006
Many Enemies, Much Honour?
For 20 years Dr. Pandalis has been passionately investing time and energy in cistus research which is involving high expenses. Dr. Pandalis received the basis of his knowledge and interest for Pink Rockrose by his grandmother, when he was a child in his homeland Greece. This traditional knowledge of Pink Rockrose, a plant which has been known for centuries, provided a basis for biologist´s and biochemist´s Georgios Pandalis research. Very soon scientific work yielded fruit such as successful assays, experiments, and clinical trials. Among others Berliner Charité Universitätskliniken, Institut für Molekulare Virologie in Münster, LEFO-Institut Ahrensburg, Friedrich-Löffler-Institut Tübingen, as well as a lot of physicians and alternative practitioners took part in research. Results of research gave reason to great hope. Pink Rockrose underwent an impressing resurrection. The plant was on its way to become a star. On 24th of October, last year, the hype peaked out, when a TV broadcast about Cistus was on air, produced for Channel One by Report München. From this time on copyists and imitators are mushrooming. Providers are advertising their own products by using the assays and clinical trials which had been initialised and ordered by Dr. Pandalis. This is very confusing for consumers and customers.
The important and vital fact is the following one: All these assays exclusively refer to Dr. Pandalis Special Extract Cystus®052, which is made of the variety Cistus incanus PANDALIS. This special variety, which has an extremely high anti-viral activity, is menaced of extermination by ignorant free riders. That is why Dr. Pandalis has registered this Cistus-plant at the European Authorities for Sorts (Euuzropäisches Sortenamt). The application of Cistus in case of influenza has been patented, too!
New Dr. Pandalis Original Products:
Cystus®052 Infektblocker Tabletten
Cystus®052 Brew for Gargling
Avian Flu - a Clarification
On the occasion of the present situation we feel obliged to attract attention to some statements of advertisement which do not come from our company. In the Internet more and more offerers appear publishing phrases such as "recommended in case of avian flu" or "....helps to fight avian flu". We strictly distance ourselves from every kind of advertisement in connexion with avian flu. As a reputable and responsible company we dislike unfair scare tactics. To tell it explicitly: in Central Europe there are not any people down with avian flu. According to this fact clinical tests of products for the "treatment" of avian flu do not exist.